XTX Topco’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,381
| Closed | -$142K | – | 3073 |
|
|
2024
Q3 | $142K | Sell |
27,381
-42,545
| -61% | -$221K | 0.01% | 1538 |
|
|
2024
Q2 | $180K | Buy |
69,926
+15,267
| +28% | +$39.2K | 0.02% | 1277 |
|
|
2024
Q1 | $269K | Buy |
+54,659
| New | +$269K | 0.04% | 943 |
|
|
2023
Q4 | – | Sell |
-19,908
| Closed | -$228K | – | 2258 |
|
|
2023
Q3 | $228K | Buy |
19,908
+2,382
| +14% | +$27.3K | 0.04% | 935 |
|
|
2023
Q2 | $444K | Buy |
17,526
+7,311
| +72% | +$185K | 0.08% | 443 |
|
|
2023
Q1 | $329K | Sell |
10,215
-24
| -0.2% | -$773 | 0.07% | 582 |
|
|
2022
Q4 | $189K | Buy |
+10,239
| New | +$189K | 0.04% | 867 |
|
|
2021
Q3 | – | Sell |
-7,323
| Closed | -$217K | – | 1129 |
|
|
2021
Q2 | $217K | Buy |
+7,323
| New | +$217K | 0.07% | 527 |
|